1. Home
  2. ACOG vs SILC Comparison

ACOG vs SILC Comparison

Compare ACOG & SILC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACOG
  • SILC
  • Stock Information
  • Founded
  • ACOG 2000
  • SILC 1987
  • Country
  • ACOG Canada
  • SILC Israel
  • Employees
  • ACOG N/A
  • SILC N/A
  • Industry
  • ACOG
  • SILC Computer Manufacturing
  • Sector
  • ACOG
  • SILC Technology
  • Exchange
  • ACOG Nasdaq
  • SILC Nasdaq
  • Market Cap
  • ACOG 80.3M
  • SILC 86.2M
  • IPO Year
  • ACOG N/A
  • SILC 1994
  • Fundamental
  • Price
  • ACOG $10.35
  • SILC $15.27
  • Analyst Decision
  • ACOG Strong Buy
  • SILC Hold
  • Analyst Count
  • ACOG 1
  • SILC 2
  • Target Price
  • ACOG $20.00
  • SILC N/A
  • AVG Volume (30 Days)
  • ACOG 62.9K
  • SILC 12.6K
  • Earning Date
  • ACOG 08-14-2025
  • SILC 07-31-2025
  • Dividend Yield
  • ACOG N/A
  • SILC N/A
  • EPS Growth
  • ACOG N/A
  • SILC N/A
  • EPS
  • ACOG N/A
  • SILC N/A
  • Revenue
  • ACOG $2,928,654.00
  • SILC $58,134,000.00
  • Revenue This Year
  • ACOG N/A
  • SILC $6.26
  • Revenue Next Year
  • ACOG N/A
  • SILC $19.14
  • P/E Ratio
  • ACOG N/A
  • SILC N/A
  • Revenue Growth
  • ACOG N/A
  • SILC N/A
  • 52 Week Low
  • ACOG $3.75
  • SILC $11.35
  • 52 Week High
  • ACOG $11.54
  • SILC $18.24
  • Technical
  • Relative Strength Index (RSI)
  • ACOG N/A
  • SILC 50.22
  • Support Level
  • ACOG N/A
  • SILC $14.93
  • Resistance Level
  • ACOG N/A
  • SILC $15.93
  • Average True Range (ATR)
  • ACOG 0.00
  • SILC 0.55
  • MACD
  • ACOG 0.00
  • SILC -0.01
  • Stochastic Oscillator
  • ACOG 0.00
  • SILC 31.78

About ACOG Alpha Cognition Inc. Common Stock

Alpha Cognition Inc is a biopharmaceutical company dedicated to developing treatments for patients suffering from neurodegenerative diseases, such as Alzheimer's disease, for which there are limited or no treatment options. The Company's current focus is on the commercial manufacturing and sales of ZUNVEYL oral tablet formulation. The Company's commercial development program for ZUNVEYL is primarily focused on building a long-term care commercial team that can focus on providing key points of differentiation, exploiting key issues with existing Acetylcholinesterase inhibitors treatments, and seeking potential licensing partners for other additional indications and new formulations.

About SILC Silicom Ltd

Silicom Ltd designs and manufactures networking and data infrastructure solutions for various servers, server-based systems, and communications devices. Its product categories consist of Server Adapters, Edge Networking Solutions, FPGA-Based Cards, x86 Open Appliances, Bypass Switches, and TAPs. Geographically, it derives a majority of its revenue from North America and also has a presence in Europe and Asia-Pacific.

Share on Social Networks: